Related Experiment Videos
Potent interaction of flavopiridol with MRP1
J H Hooijberg1, H J Broxterman, G L Scheffer
1Department of Medical Oncology, Academisch Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands.
British Journal of Cancer
|September 25, 1999
Summary
Flavopiridol, a synthetic flavonoid, potently interacts with multidrug resistance protein 1 (MRP1), enhancing anticancer drug accumulation. This interaction is crucial for flavopiridol
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Multidrug resistance protein 1 (MRP1) is an ATP-dependent transporter involved in drug efflux.
- MRP1 confers resistance to various anticancer agents.
- Flavopiridol is a synthetic flavonoid with antiproliferative properties undergoing clinical trials.
Purpose of the Study:
- To investigate the interaction between flavopiridol and MRP1.
- To determine the effect of flavopiridol on MRP1-mediated transport and ATPase activity.
- To assess the role of MRP1 in cellular resistance to flavopiridol.
Main Methods:
- Enzyme kinetics to measure MRP1 ATPase activity.
- Use of a specific monoclonal antibody (MIB6) against MRP1.
- Cellular accumulation assays with daunorubicin in MRP1-overexpressing cells.
- Assessment of cellular resistance to flavopiridol in transfected cells.
Main Results:
- Flavopiridol and other (iso)flavonoids stimulate MRP1 ATPase activity dose-dependently.
- A specific antibody against MRP1 inhibits this stimulated ATPase activity.
- Flavopiridol increases daunorubicin accumulation in MRP1-overexpressing cells, particularly at low concentrations.
- MRP1-overexpressing cells exhibit resistance to flavopiridol.
Conclusions:
- Flavopiridol interacts with and modulates MRP1 activity.
- MRP1 contributes to cellular resistance to flavopiridol.
- These findings have implications for developing anticancer therapies involving flavopiridol and MRP1 modulation.